An optimized PanFlu-IOA-based mRNA vaccine targeting hemagglutinin confers broad-spectrum protection against heterosubtypic influenza viruses in mice
The rapid mutation rate of influenza viruses necessitates annual updates of vaccine formulations, underscoring the urgent need for a universal influenza vaccine. Current computationally optimized antigen strategies are mostly confined to certain subtypes and thus fail to elicit broad-spectrum immunity against heterosubtypic strains. Here, we developed the PanFlu-IOA (Pan-Influenza Iteratively Optimized Antigen) toolkit to overcome systemic bias and extract universal antigenic features across diverse evolutionary branches. Using this toolkit, we generated two universal hemagglutinin (HA) sequences G1-HA and G2-HA for influenza virus Group 1 and Group 2, respectively. These two HAs were incorporated into an mRNA-lipid nanoparticle system to construct a broad-spectrum vaccine candidate termed panFluA. In mice, panFluA elicits robust cross-reactive humoral immunity, Th1-biased systemic CD4⁺ T cell responses, and cytotoxic CD8⁺ T cell activation, while successfully establishing durable lung-resident memory T cells. Notably, panFluA conferred potent cross-protection against lethal challenges with highly divergent Group 1 and Group 2 influenza viruses. Mechanistic studies revealed that this protection was mediated by the coordinated action of humoral and cellular immunity, as confirmed by T-cell depletion and passive serum transfer experiments. Overall, panFluA induced broad immune responses against conserved HA antigens. Our study provides a general strategy for next-generation universal influlenza vaccines. Researchers developed PanFlu-IOA, a computational approach to design a broad spectrum mRNA influenza vaccine. The vaccine induced broad immune responses and protected mice against multiple influenza subtypes, offering a path to universal vaccines.
Authors
- Yang Xi (ORCID: https://orcid.org/0000-0002-0648-1728)
- Man Xing (ORCID: https://orcid.org/0000-0002-6076-2547)
- Weiqian Dai
- Shulei Jia (ORCID: https://orcid.org/0000-0003-2483-0300)
- Dongming Zhou (ORCID: https://orcid.org/0000-0002-5989-7591)
- Ping Zhou (ORCID: https://orcid.org/0000-0002-1738-2864)
- Yao Yan (ORCID: https://orcid.org/0009-0004-4523-5134)
- Xiang Wang (ORCID: https://orcid.org/0000-0002-7215-0441)
- Caihong Zhu
- Hongyang Shi
- Wenying Zhao
- Ying Li
Institutions
- Fudan University (CN)
- Shanghai Public Health Clinical Center (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-11-15
- DOI
- https://doi.org/10.1038/s41467-026-79813-x
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00